|
|
|
ONLINE FEATURES
Book Reviews
BW Video
Columnists
Interactive Gallery
Newsletters
Past Covers
Philanthropy
Podcasts
Special Reports
BLOGS
Auto Beat
Bangalore Tigers
Blogspotting
Brand New Day
Byte of the Apple
Economics Unbound
Eye on Asia
Fine On Media
Green Biz
Hot Property
Investing Insights
Management IQ
NEXT: Innovation
NussbaumOnDesign
Tech Beat
Working Parents
TECHNOLOGY
J.D. Power Ratings
Product Reviews
Tech Stats
Wildstrom: Tech Maven
AUTOS
Home Page
Auto Reviews
Classic Cars
Car Care & Safety
Hybrids
INNOVATION
& DESIGN Home Page Architecture Brand Equity Auto Design Game Room SMALLBIZ Smart Answers Success Stories Today's Tip INVESTING Investing: Europe Annual Reports BW 50 S&P Picks & Pans Stock Screeners Free S&P Stock Report SCOREBOARDS Hot Growth 100 Mutual Funds Info Tech 100 S&P 500 B-SCHOOLS Undergrad Programs MBA Blogs MBA Profiles MBA Rankings Who's Hiring Grads |  |
MAY 28, 2007
VeriChip Is I.D.'d As A Winner  Verichip (CHIP
) is starting to attract Wall Street with its Food & Drug Administration-approved human-implantable radio frequency identification (RFID) chip for medical use. The size of a grain of rice, it can be injected into a person's arm. When scanned, it shows a 16-digit code linked to the person's proprietary database containing pertinent medical records. "It's an amazing life-saving technology and has many uses," says William Woodward of Anthem Venture Partners, which bought shares at VeriChip's initial public offering on Feb. 8 at 6.50 a share. The stock has since slid to 4.28. But Woodward is confident it will hit 12 in a year as more doctors and hospitals sign up to use the system. Some 400 hospitals and 1,200 physicians have already done so. Kevin Dede of investment firm Merriman Curhan Ford (MEM
), which has done banking for VeriChip, says the RFID chip is critical for people who end up in hospitals in an unconscious state. He expects sales to leap from $27.3 million in 2006 to $30.2 million in 2007 and $36 million in 2008. VeriChip has yet to make money.
Note: Unless otherwise noted, neither the sources cited in Inside Wall Street nor their firms hold positions in the stocks under discussion. Similarly, they have no investment banking or other financial relationships with them.  By Gene G. Marcial
BW MALL
SPONSORED LINKS
Get BusinessWeek directly on your desktop with our RSS feeds.
Buy a link now! Add BusinessWeek news to your Web site with our headline feed. Click to buy an e-print or reprint of a BusinessWeek or BusinessWeek Online story or video. To subscribe online to BusinessWeek magazine, please click here. Learn more, go to the BusinessWeekOnline home page  | | |
 Copyright 2007, by The McGraw-Hill Companies Inc. All rights reserved.Terms of Use | Privacy Notice |
Printer-Friendly Version